SCHEMBL7328512

SCHEMBL7328512

Cc1[nH]c(-c2ccccc2)cc1C=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.66
NPC1 O15118 3/20 0.66
BRD4 O60885 1/20 0.51
KDM4E B2RXH2 7/20 0.41
HPGD P15428 4/20 0.41
HSD17B10 Q99714 4/20 0.41
LMNA P02545 4/20 0.41
GAA P10253 3/20 0.41
TP53 P04637 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 5/20 0.41
TSHR P16473 1/20 0.41
TAS2R38 P59533 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
CTSV O60911 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13568570 0.80 ALDH1A1 (0.49) RAB9ANPC1KDM4EHPGDLMNA
SCHEMBL27642153 0.79 NPC1 (0.68) RAB9ANPC1BRD4KDM4EHPGD
SCHEMBL15572536 0.79 NPC1 (1.00) RAB9ANPC1KDM4EHPGDHSD17B10
SCHEMBL7329075 0.74 RAB9A (0.51) RAB9ANPC1BRD4KDM4EHPGD
SCHEMBL21757291 0.74 BRD4 (0.55) RAB9ANPC1BRD4KDM4EHPGD
SCHEMBL16976741 0.72 PDE4A (0.55) RAB9ANPC1BRD4KDM4EHPGD
SCHEMBL11016316 0.71 BRD4 (0.56) RAB9ANPC1BRD4KDM4EHPGD
SCHEMBL6957694 0.71 BRD4 (0.56) RAB9ANPC1BRD4KDM4EHPGD
SCHEMBL2215320 0.70 BRD4 (0.75) BRD4KDM4EMAPTALDH1A1TAS2R38
SCHEMBL24697352 0.69 BRD4 (0.54) RAB9ANPC1BRD4KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009148004-A1 NOVEL COMPOUND AND PHARMACEUTICAL APPLICATION OF SAME 株式会社 三和化学研究所 (JP) 2009-12-10 WO disclosed
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 WO disclosed